Abstract:Abstract Background Intercellular communication is mediated by extracellular vesicles (EVs), as they enclose selectively packaged biomolecules that can be horizontally transferred from donor to recipient cells. Because all cells constantly generate and recycle EVs, they provide accurate timed snapshots of individual pathophysiological status. Since blood plasma circulates through the whole body, it is often the biofluid of choice for biomarker detection in EVs. Blood collection is easy and minimally invasive, yet reproducible procedures to obtain pure EV samples from circulating biofluids are still lacking. Here, we addressed central aspects of EV immunoaffinity isolation from simple and complex matrices, such as plasma. Methods Cell-generated EV spike-in models were isolated and purified by size-exclusion chromatography, stained with cellular dyes and characterized by nano flow cytometry. Fluorescently-labelled spike-in EVs emerged as reliable, high-throughput and easily measurable readouts, which were employed to optimize our EV immunoprecipitation strategy and evaluate its performance. Plasma-derived EVs were captured and detected using this straightforward protocol, sequentially combining isolation and staining of specific surface markers, such as CD9 or CD41. Multiplexed digital transcript detection data was generated using the Nanostring nCounter platform and evaluated through a dedicated bioinformatics pipeline. Results Beads with covalently-conjugated antibodies on their surface outperformed streptavidin-conjugated beads, coated with biotinylated antibodies, in EV immunoprecipitation. Fluorescent EV spike recovery evidenced that target EV subpopulations can be efficiently retrieved from plasma, and that their enrichment is dependent not only on complex matrix composition, but also on the EV surface phenotype. Finally, mRNA profiling experiments proved that distinct EV subpopulations can be captured by directly targeting different surface markers. Furthermore, EVs isolated with anti-CD61 beads enclosed mRNA expression patterns that might be associated to early-stage lung cancer, in contrast with EVs captured through CD9, CD63 or CD81. The differential clinical value carried within each distinct EV subset highlights the advantages of selective isolation. Conclusions This EV isolation protocol facilitated the extraction of clinically useful information from plasma. Compatible with common downstream analytics, it is a readily implementable research tool, tailored to provide a truly translational solution in routine clinical workflows, fostering the inclusion of EVs in novel liquid biopsy settings.

Analysis of extracellular vesicle mRNA derived from plasma using the nCounter platform

Digital Profiling of Tumor Extracellular Vesicle-associated RNAs Directly from Unprocessed Blood Plasma

Single Extracellular Vesicle Analysis Using Droplet Microfluidics.

Exploiting gene expression profiles of circulating extracellular vesicles for breast cancer detection

Peptide-based capture-and-release purification of extracellular vesicles and statistical algorithm enabled quality assessment

Profiling Extracellular Long RNA Transcriptome in Human Plasma and Extracellular Vesicles for Biomarker Discovery

LncRNA Quantification from Extracellular Vesicles Isolated from Blood Plasma or Conditioned Media

Sequencing-Based Protein Analysis of Single Extracellular Vesicles.

Selective isolation of extracellular vesicles from minimally processed human plasma as a translational strategy for liquid biopsies

Methods for Collection of Extracellular Vesicles and Their Content RNA as Liquid Biopsy for Lung Cancer Detection: Application of Differential Centrifugation and Annexin A5 Coated Beads

Extracellular vesicles isolated by size-exclusion chromatography present suitability for RNomics analysis in plasma

CRISPR/Cas13a‐Based MicroRNA Detection in Tumor‐Derived Extracellular Vesicles

Characterizing Extracellular Vesicles and Their Diverse RNA Contents

High-Throughput Simultaneous Mrna Profiling Using Ncounter Technology Demonstrates That Extracellular Vesicles Contain Different Mrna Transcripts Than Their Parental Prostate Cancer Cells

Profiling extracellular vesicle surface proteins with 10 µL peripheral plasma within 4 h

Plasma-Derived Extracellular Vesicle Proteins As A Source Of Biomarkers For Lung Adenocarcinoma

Quantitative and Multiplex Detection of Extracellular Vesicle‐Derived MicroRNA via Rolling Circle Amplification within Encoded Hydrogel Microparticles

Plasma extracellular vesicles detected by Single Molecule array technology as a liquid biopsy for colorectal cancer

Optimized procedure for high-throughput transcriptome profiling of small extracellular vesicles isolated from low volume serum samples

A magneto-activated nanoscale cytometry platform for molecular profiling of small extracellular vesicles

High-throughput, multiplexed quantification, and sorting of single EVs at single-molecule level